Lipid mediators of inflammation in rheumatoid arthritis and osteoarthritis

Best Practice and Research: Clinical Rheumatology

Volumn 29, Issue 6, 2015, Pages 741-755

  Brouwers, Hilde ^a   Von Hegedus, Joost ^a   Toes, René ^a   Kloppenburg, Margreet ^a   Ioan Facsinay, Andreea ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammation; Lipid mediators; Lipids; Osteoarthritis; Oxylipins; Rheumatoid arthritis

Indexed keywords

CHOLESTEROL; FATTY ACID DERIVATIVE; LIPOPROTEIN; OXYLIPIN; PHOSPHOLIPID; AUTACOID; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT;

CHOLESTEROL METABOLISM; CLINICAL FEATURE; HUMAN; IN VITRO STUDY; INFLAMMATION; INTERVENTION STUDY; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL; ANIMAL; CHEMISTRY; METABOLISM; MOUSE; PATHOLOGY; SYNOVIAL FLUID;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MICE; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 84959533235     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2016.02.003     Document Type: Review

References (114)

1. E. Yusuf, M.C. Kortekaas, I. Watt, and et al. Do knee abnormalities visualised on MRI explain knee pain in knee osteoarthritis? A systematic review Annals of the Rheumatic Diseases 70 2011 60 67
2. F. Berenbaum Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!) Osteoarthritis and Cartilage 21 2013 16 21
3. J.F. Boyer, P.A. Gourraud, A. Cantagrel, and et al. Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis Joint Bone Spine 78 2011 179 183
4. M.W. de, P.M. van der Kraan, W.B. van den Berg, and et al. High systemic levels of low-density lipoprotein cholesterol: fuel to the flames in inflammatory osteoarthritis? 2015 Rheumatology Oxford
5. O. Quehenberger, A.M. Armando, A.H. Brown, and et al. Lipidomics reveals a remarkable diversity of lipids in human plasma Journal of Lipid Research 51 2010 3299 3305
6. S.P. Young, S.R. Kapoor, M.R. Viant, and et al. The impact of inflammation on metabolomic profiles in patients with arthritis Arthritis & Rheumatism 65 2013 2015 2023
7. M.J. Ormseth, L.L. Swift, S. Fazio, and et al. Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis Atherosclerosis 219 2011 869 874
8. B. Fuchs, A. Bondzio, U. Wagner, and et al. Phospholipid compositions of sera and synovial fluids from dog, human and horse: a comparison by 31P-NMR and MALDI-TOF MS Journal of Animal Physiology and Animal Nutricion 93 2009 410 422
9. B. Fuchs, J. Schiller, U. Wagner, and et al. The phosphatidylcholine/lysophosphatidylcholine ratio in human plasma is an indicator of the severity of rheumatoid arthritis: investigations by 31P NMR and MALDI-TOF MS Clinical Biochemistry 38 2005 925 933
10. M. Moghaddami, E. Ranieri, M. James, and et al. Prostaglandin D(2) in inflammatory arthritis and its relation with synovial fluid dendritic cells Mediators of Inflammation 2013 2013 329494
11. M. Giera, A. Ioan-Facsinay, R. Toes, and et al. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS Biochimica et Biophysica Acta 1821 2012 1415 1424
12. M.K. Kosinska, G. Liebisch, G. Lochnit, and et al. A lipidomic study of phospholipid classes and species in human synovial fluid Arthritis & Rheumatism 65 2013 2323 2333
13. M.K. Kosinska, T.E. Ludwig, G. Liebisch, and et al. Articular joint lubricants during osteoarthritis and rheumatoid arthritis display altered levels and molecular species PLoS One 10 2015 e0125192
14. M. Korotkova, and P.J. Jakobsson Persisting eicosanoid pathways in rheumatic diseases Nature Reviews Rheumatology 10 2014 229 241
15. T. Hishinuma, H. Nakamura, T. Sawai, and et al. Microdetermination of prostaglandin E2 in joint fluid in rheumatoid arthritis patients using gas chromatography/selected ion monitoring Prostaglandins & Other Lipid Mediators 58 1999 179 186
16. W. Pruzanski, P. Vadas, J. Kim, and et al. Phospholipase A2 activity associated with synovial fluid cells The Journal of Rheumatology 15 1988 791 794
17. J.J. Seilhamer, S. Plant, W. Pruzanski, and et al. Multiple forms of phospholipase A2 in arthritic synovial fluid The Journal of Biochemistry 106 1989 38 42
18. M. Westman, M. Korotkova, K.E. af, and et al. Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium Arthritis & Rheumatism 50 2004 1774 1780
19. M. Murakami, K. Nakashima, D. Kamei, and et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2 The Journal of Biological Chemistry 278 2003 37937 37947
20. X.T. Shao, L. Feng, L.J. Gu, and et al. Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis Clinical and Experimental Medicine 9 2009 215 221
21. C.N. Serhan, N. Chiang, and J. Dalli The resolution code of acute inflammation: novel pro-resolving lipid mediators in resolution Seminars in Immunology 27 2015 200 215
22. H. Nochi, H. Tomura, M. Tobo, and et al. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells The Journal of Immunology 181 2008 5111 5119
23. V. Limaye, P. Xia, C. Hahn, and et al. Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells Cellular and Molecular Biology Letters 14 2009 424 441
24. H.Y. Song, M.J. Lee, M.Y. Kim, and et al. Lysophosphatidic acid mediates migration of human mesenchymal stem cells stimulated by synovial fluid of patients with rheumatoid arthritis Biochimica et Biophysica Acta 1801 2010 23 30
25. I. Nikitopoulou, N. Oikonomou, E. Karouzakis, and et al. Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis The Journal of Experimental Medicine 209 2012 925 933
26. J.M. Castro-Perez, J. Kamphorst, J. DeGroot, and et al. Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients Journal of Proteome Research 9 2010 2377 2389
27. S. Basu, M. Whiteman, D.L. Mattey, and et al. Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases Annals of the Rheumatic Diseases 60 2001 627 631
28. M. Attur, S. Krasnokutsky, A. Statnikov, and et al. Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers Arthritis & Rheumatology 67 2015 2905 2915
29. S.A. Rae, E.M. Davidson, and M.J. Smith Leukotriene B4, an inflammatory mediator in gout Lancet 1982 1122 1124
30. T.H. Lee, R.L. Hoover, J.D. Williams, and et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function The New England Journal of Medicine 312 1985 1217 1224
31. E.A. Miles, and P.C. Calder Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis British Journal of Nutrition 107 Suppl. 2 2012 S171 S184
32. H.M. Vidgren, J.J. Agren, U. Schwab, and et al. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men Lipids 32 1997 697 705
33. C. Skarke, N. Alamuddin, J.A. Lawson, and et al. Bioactive products formed in humans from fish oils The Journal of Lipid Research 56 2015 1808 1820
34. Y. Park, A. Lee, S.C. Shim, and et al. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea The Journal of Nutritional Biochemistry 24 2013 1367 1372
35. C. Dawczynski, U. Hackermeier, M. Viehweger, and et al. Incorporation of n-3 PUFA and gamma-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis-a randomized controlled human intervention trial Lipids in Health and Disease 10 2011 130
36. S.M. Proudman, M.J. James, L.D. Spargo, and et al. Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use Annals of the Rheumatic Diseases 74 2015 89 95
37. D. Di Giuseppe, A. Crippa, N. Orsini, and et al. Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis Arthritis Research & Therapy 16 2014 446
38. D. Di Giuseppe, A. Wallin, M. Bottai, and et al. Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women Annals of the Rheumatic Diseases 73 2014 1949 1953
39. R.W. Gan, K.A. Young, G.O. Zerbe, and et al. Lower omega-3 fatty acids are associated with the presence of anti-cyclic citrullinated peptide autoantibodies in a population at risk for future rheumatoid arthritis: a nested case-control study Rheumatology Oxford 55 2015 367 376
40. C.A. Leslie, W.A. Gonnerman, M.D. Ullman, and et al. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice The Journal of Experimental Medicine 162 1985 1336 1349
41. M. Ierna, A. Kerr, H. Scales, and et al. Supplementation of diet with krill oil protects against experimental rheumatoid arthritis BMC Musculoskeletal Disorders 11 2010 136
42. E.Y. Lee, C.K. Lee, K.U. Lee, and et al. Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice Rheumatology International 27 2007 225 233
43. Y.S. Hah, M.J. Sung, H.S. Lim, and et al. Dietary alpha lipoic acid supplementation prevents synovial inflammation and bone destruction in collagen-induced arthritic mice Rheumatology International Int 31 2011 1583 1590
44. B. Orosa, S. Garcia, P. Martinez, and et al. Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis Annals of the Rheumatic Diseases 73 2014 298 305
45. G. Eros, S. Ibrahim, N. Siebert, and et al. Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis Arthritis Research & Therapy 11 2009 R43
46. W. Zhang, S. Likhodii, Y. Zhang, and et al. Classification of osteoarthritis phenotypes by metabolomics analysis BMJ Open 4 2014 e006286
47. M.K. Kosinska, G. Liebisch, G. Lochnit, and et al. Sphingolipids in human synovial fluid-a lipidomic study PLoS One 9 2014 e91769
48. K.R. Baker, N.R. Matthan, A.H. Lichtenstein, and et al. Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee: the MOST study Osteoarthritis and Cartilage 20 2012 382 387
49. L. Lippiello, T. Walsh, and M. Fienhold The association of lipid abnormalities with tissue pathology in human osteoarthritic articular cartilage Metabolism 40 1991 571 576
50. M. Zawadzki, C. Janosch, and J. Szechinski Perna canaliculus lipid complex PCSO-524 demonstrated pain relief for osteoarthritis patients benchmarked against fish oil, a randomized trial, without placebo control Marine drugs 11 2013 1920 1935
51. T. Stammers, B. Sibbald, and P. Freeling Efficacy of cod liver oil as an adjunct to non-steroidal anti-inflammatory drug treatment in the management of osteoarthritis in general practice Annals of the Rheumatic Diseases 51 1992 128 129
52. C.L. Hill, L.M. March, D. Aitken, and et al. Fish oil in knee osteoarthritis: a randomised clinical trial of low dose versus high dose Annals of the Rheumatic Diseases 2015 10.1136/annrheumdis-2014-207169
53. D.T. Felson, and H.A. Bischoff-Ferrari Dietary fatty acids for the treatment of OA, including fish oil Annals of the Rheumatic Diseases 75 2016 1 2
54. L. Knott, N.C. Avery, A.P. Hollander, and et al. Regulation of osteoarthritis by omega-3 (n-3) polyunsaturated fatty acids in a naturally occurring model of disease Osteoarthritis and Cartilage 19 2011 1150 1157
55. C.L. Wu, D. Jain, J.N. McNeill, and et al. Dietary fatty acid content regulates wound repair and the pathogenesis of osteoarthritis following joint injury Annals of the Rheumatic Diseases 74 2015 2076 2083
56. K.W. Frommer, A. Schaffler, S. Rehart, and et al. Free fatty acids: potential proinflammatory mediators in rheumatic diseases Annals of the Rheumatic Diseases 74 2015 303 310
57. G. Colantuoni, M. Quintero, A. Panasyuk, and et al. Do arachidonic acid and its metabolites, secreted by rheumatoid and osteoarthritic synovial tissue, account for the strong inhibition of DNA synthesis in cultured human articular chondrocytes? A novel approach to the mechanism of tissue damage Joint Bone Spine 72 2005 533 539
58. B.A. Watkins, H.E. Lippman, B.L. Le, and et al. Bioactive fatty acids: role in bone biology and bone cell function Progress in Lipid Research 40 2001 125 148
59. J.M. Kremer, D.A. Lawrence, W. Jubiz, and et al. Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects Arthritis & Rheumatism 33 1990 810 820
60. M. Magaro, L. Altomonte, A. Zoli, and et al. Influence of diet with different lipid composition on neutrophil chemiluminescence and disease activity in patients with rheumatoid arthritis Annals of the Rheumatic Diseases 47 1988 793 796
61. N. Moghaddami, J. Irvine, X. Gao, and et al. Novel action of n-3 polyunsaturated fatty acids: inhibition of arachidonic acid-induced increase in tumor necrosis factor receptor expression on neutrophils and a role for proteases Arthritis & Rheumatism 56 2007 799 808
62. A.J. de Jong, M. Kloppenburg, R.E. Toes, and et al. Fatty acids, lipid mediators, and T-cell function Frontiers in Immunology 5 2014 483
63. S.R. Shaikh, and H. Teague N-3 fatty acids and membrane microdomains: from model membranes to lymphocyte function Prostaglandins, Leukotrienes & Essential Fatty Acids 87 2012 205 208
64. I. Sevastou, E. Kaffe, M.A. Mouratis, and et al. Lysoglycerophospholipids in chronic inflammatory disorders: the PLA(2)/LPC and ATX/LPA axes Biochimica et Biophysica Acta 1831 2013 42 60
65. Y. Miyabe, C. Miyabe, Y. Iwai, and et al. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade Arthritis Research & Therapy 16 2014 461
66. Y. Rikitake, K. Hirata, S. Kawashima, and et al. Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine Biochemical and Biophysical Research Communications 281 2001 1291 1297
67. V. Ruiperez, J. Casas, M.A. Balboa, and et al. Group V phospholipase A2-derived lysophosphatidylcholine mediates cyclooxygenase-2 induction in lipopolysaccharide-stimulated macrophages The Journal of Immunology 179 2007 631 638
68. M. Kitano, T. Hla, M. Sekiguchi, and et al. Sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 signaling in rheumatoid synovium: regulation of synovial proliferation and inflammatory gene expression Arthritis & Rheumatism 54 2006 742 753
69. K. Masuko, M. Murata, H. Nakamura, and et al. Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes BMC Musculoskeletal Disorders 8 2007 29
70. C. Sato, T. Iwasaki, S. Kitano, and et al. Sphingosine 1-phosphate receptor activation enhances BMP-2-induced osteoblast differentiation Biochemical and Biophysical Research Communications 423 2012 200 205
71. Y.M. Bastiaansen-Jenniskens, M. Siawash, C.H. van de Lest, and et al. Monounsaturated and saturated, but not n-6 polyunsaturated fatty acids decrease cartilage destruction under inflammatory conditions: a preliminary study Cartilage 4 2013 321 328
72. O. Alvarez-Garcia, N.H. Rogers, R.G. Smith, and et al. Palmitate has proapoptotic and proinflammatory effects on articular cartilage and synergizes with interleukin-1 Arthritis & Rheumatology 66 2014 1779 1788
73. L. Raichel, S. Berger, N. Hadad, and et al. Reduction of cPLA2alpha overexpression: an efficient anti-inflammatory therapy for collagen-induced arthritis European Journal of Immunology 38 2008 2905 2915
74. M. Chen, E. Boilard, P.A. Nigrovic, and et al. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis Arthritis & Rheumatism 58 2008 1354 1365
75. L.K. Myers, A.H. Kang, A.E. Postlethwaite, and et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis Arthritis & Rheumatism 43 2000 2687 2693
76. C.E. Trebino, J.L. Stock, C.P. Gibbons, and et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase Proceedings of the National Academy of Sciences of the United Stated of America 100 2003 9044 9049
77. P. Clark, S.E. Rowland, D. Denis, and et al. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbe nzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis Journal of Pharmacology and Experimental Therapeutics 325 2008 425 434
78. C.A. Christianson, M. Corr, G.S. Firestein, and et al. Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis Pain 151 2010 394 403
79. D.B. Bas, J. Su, K. Sandor, and et al. Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency Arthritis & Rheumatism 64 2012 3886 3896
80. M.M. Chan, and A.R. Moore Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production The Journal of Immunology 184 2010 6418 6426
81. F.P. Conte, O. Menezes-de-Lima Jr., W.A. Verri Jr., and et al. Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects British Journal of Pharmacology 161 2010 911 924
82. J. Martel-Pelletier, J.P. Pelletier, and H. Fahmi Cyclooxygenase-2 and prostaglandins in articular tissues Seminars in Arthritis and Rheumatism 33 2003 155 167
83. M. Korotkova, M. Westman, K.R. Gheorghe, and et al. Effects of antirheumatic treatments on the prostaglandin E2 biosynthetic pathway Arthritis & Rheumatism 52 2005 3439 3447
84. S. Garner, D. Fidan, R. Frankish, and et al. Celecoxib for rheumatoid arthritis Cochrane Database of Systematic Reviews 2002 CD003831
85. T. Gursel, S. Firat, and Z.S. Ercan Increased serum leukotriene B4 level in the active stage of rheumatoid arthritis in children Prostaglandins, Leukotrienes & Essential Fatty Acids 56 1997 205 207
86. N. Ahmadzadeh, M. Shingu, M. Nobunaga, and et al. Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids Inflammation 15 1991 497 503
87. M. Chen, B.K. Lam, Y. Kanaoka, and et al. Neutrophil-derived leukotriene B4 is required for inflammatory arthritis The Journal of Experimental Medicine 203 2006 837 842
88. R.C. Chou, N.D. Kim, C.D. Sadik, and et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis Immunity 33 2010 266 278
89. W.H. Shao, P.A. Del, C.B. Bock, and et al. Targeted disruption of leukotriene B4 receptors BLT1 and BLT2: a critical role for BLT1 in collagen-induced arthritis in mice The Journal of Immunology 176 2006 6254 6261
90. M.E. Weinblatt, J.M. Kremer, J.S. Coblyn, and et al. Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis The Journal of Rheumatology 19 1992 1537 1541
91. R.R. Bannuru, C.H. Schmid, D.M. Kent, and et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis Annals of Internal Medicine 162 2015 46 54
92. K. Sengupta, K.V. Alluri, A.R. Satish, and et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee Arthritis Research & Therapy 10 2008 R85
93. A.F. Cicero, and L. Laghi Activity and potential role of licofelone in the management of osteoarthritis Journal of Clinical Interventions in Aging 2 2007 73 79
94. J.P. Raynauld, J. Martel-Pelletier, P. Bias, and et al. Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI Annals of the Rheumatic Diseases 68 2009 938 947
95. D.V. Jovanovic, J.C. Fernandes, J. Martel-Pelletier, and et al. In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: suppression of collagenase 1 and interleukin-1beta synthesis Arthritis & Rheumatism 44 2001 2320 2330
96. M. Moreau, C. Boileau, J. Martel-Pelletier, and et al. Licofelone reduces progression of structural changes in a canine model of osteoarthritis under curative conditions: effect on protease expression and activity The Journal of Rheumatology 33 2006 1176 1183
97. C. Boileau, J.P. Pelletier, G. Tardif, and et al. The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway Annals of the Rheumatic Diseases 64 2005 891 898
98. R.M. Sommerfelt, A.J. Feuerherm, T. Skuland, and et al. Cytosolic phospholipase A2 modulates TLR2 signaling in synoviocytes PLoS One 10 2015 e0119088
99. F. Kojima, H. Naraba, Y. Sasaki, and et al. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts Arthritis & Rheumatism 48 2003 2819 2828
100. P. Wang, F. Zhu, and K. Konstantopoulos Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Delta(12,14)-PGJ2 PLoS One 6 2011 e27630
101. T. Shibata-Nozaki, H. Ito, H. Mitomi, and et al. Endogenous prostaglandin E2 inhibits aberrant overgrowth of rheumatoid synovial tissue and the development of osteoclast activity through EP4 receptor Arthritis & Rheumatism 63 2011 2595 2605
102. A.F. Sheibanie, I. Tadmori, H. Jing, and et al. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells Federation of American Societies for Experimental Biology Journal 18 2004 1318 1320
103. I.R. Klein-Wieringa, S.N. Andersen, J.C. Kwekkeboom, and et al. Adipocytes modulate the phenotype of human macrophages through secreted lipids The Journal of Immunology 191 2013 1356 1363
104. Z.Z. Shan, K. Masuko-Hongo, S.M. Dai, and et al. A potential role of 15-deoxy-delta(12,14)-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis The Journal of Biological Chemistry 279 2004 37939 37950
105. T.H. Lin, C.H. Tang, K. Wu, and et al. 15-deoxy-Delta(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-alpha-induced matrix metalloproteinase 13 production via the antagonism of NF-kappaB activation in human synovial fibroblasts Journal of Cellular Physiology 226 2011 3242 3250
106. S. Xu, H. Lu, J. Lin, and et al. Regulation of TNFalpha and IL1beta in rheumatoid arthritis synovial fibroblasts by leukotriene B4 Rheumatology International 30 2010 1183 1189
107. Z.K. Chen, H.S. Lv, and J. Jiang LTB4 can stimulate human osteoclast differentiation dependent of RANKL Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 38 2010 52 56
108. M.Y. Wu, T.H. Lin, Y.C. Chiu, and et al. Involvement of 15-lipoxygenase in the inflammatory arthritis Journal of Cellular Biochemistry 113 2012 2279 2289
109. N. Chabane, N. Zayed, M. Benderdour, and et al. Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis Arthritis Research & Therapy 11 2009 R44
110. P. Marcouiller, J.P. Pelletier, M. Guevremont, and et al. Leukotriene and prostaglandin synthesis pathways in osteoarthritic synovial membranes: regulating factors for interleukin 1beta synthesis The Journal of Rheumatology 32 2005 704 712
111. Y. Paredes, F. Massicotte, J.P. Pelletier, and et al. Study of the role of leukotriene B()4 in abnormal function of human subchondral osteoarthritis osteoblasts: effects of cyclooxygenase and/or 5-lipoxygenase inhibition Arthritis & Rheumatism 46 2002 1804 1812
112. H. Inoue, M. Takamori, Y. Shimoyama, and et al. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts British Journal of Pharmacology 136 2002 287 295
113. M. Attur, H.E. Al-Mussawir, J. Patel, and et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor The Journal of Immunology 181 2008 5082 5088
114. E.V. Tchetina, J.A. Di Battista, D.J. Zukor, and et al. Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy Arthritis Research & Therapy 9 2007 R75